$18.88
-$0.13
(-0.68%)
Quote as of 4:00 PM EST on 02/09/12
Seattle Genetics, Inc.
NASDAQ:SGEN
|
$18.88
-$0.13
(-0.68%)
|
|
| Today's Open | $19.00 |
|---|---|
| Previous Close | $19.01 |
| Daily Range | $18.72 - $19.12 |
| 52-Week Range | $12.29 - $22.40 |
| Market Cap | $2.17B |
| P/E Ratio | -13.02 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 870,254 |
| Average Daily Volume | 1,345,458 |
| Current FY EPS | -$1.39 |
SGEN Information
| Description |
|---|
| A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Biotech Investors Confident: Industry Sees Big VC Spending in 2011
Don't Read Too Much Into This Partnership
Warning: Don't Sell on This News
FDA Warns On Serious Brain Infection Risk With Lymphoma Drug Adcetris
Don't Read Too Much Into This Partnership
JPMorgan Confab Kicks Off Biotech 2012
Are These Biotech Drug Launches Back on Track?
Biotech Ideas: Top Biotech Stocks with Bullish Institutional Trends
What to Look For With Seattle Genetics in 2012
